{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:32:36Z","timestamp":1794558756379,"version":"4.9.1"},"reference-count":92,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2021,5,19]]},"DOI":"10.1080\/09546634.2019.1673877","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T05:46:23Z","timestamp":1570167983000},"page":"399-409","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":36,"title":["Off-label studies on tofacitinib in dermatology: a review"],"prefix":"10.1080","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-6991","authenticated-orcid":false,"given":"Kyle","family":"Tegtmeyer","sequence":"first","affiliation":[{"name":"Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7046-5434","authenticated-orcid":false,"given":"Jeffrey","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-5673","authenticated-orcid":false,"given":"Nolan J.","family":"Maloney","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-3988","authenticated-orcid":false,"given":"Giancarlo","family":"Atassi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Beestrum","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7600-0152","authenticated-orcid":false,"given":"Peter A.","family":"Lio","sequence":"additional","affiliation":[{"name":"Department of Dermatology & Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"},{"name":"Medical Dermatology Associates of Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,10,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2010.02.003"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1038\/370153a0"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.3410\/M4-5"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.293"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2012.10.018"},{"key":"CIT0006","unstructured":"Xeljanz (tofacitinib) [package insert]. New York, NY: Pfizer, Inc. 2018."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.2165\/11588080-000000000-00000"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31818bbea7"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2013.04.001"},{"key":"CIT0010","unstructured":"FDA. Safety trial finds risk of blood clots in the lungs and death with higher dose of tofacitinib (Xeljanz, Xeljanz XR) in rheumatoid arthritis patients; FDA to investigate [Safety Announcement]. 2019."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14018"},{"issue":"5","key":"CIT0012","first-page":"568","volume":"15","author":"Menter MA","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.01.053"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.013"},{"issue":"8","key":"CIT0015","first-page":"777","volume":"14","author":"Ports WC","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12266"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1186\/s12895-016-0051-4"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14192"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89776"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.01.032"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1159\/000494613"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.10.043"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14871"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.06.045"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13290"},{"key":"CIT0026","unstructured":"Pfizer International. Pfizer Receives Complete Response Letter from FDA for oral XELJANZ\u00ae (tofacitinib citrate) Supplemental New Drug Application for Moderate-to-Severe Chronic Plaque Psoriasis [Press Release]. 2015."},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62113-9"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13551"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1318"},{"issue":"3","key":"CIT0030","first-page":"252","volume":"13","author":"Menter A","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13258"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11168.x"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.05.004"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.037"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.09.007"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12844"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1466024"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.027"},{"key":"CIT0039","first-page":"283","volume":"97","author":"Shin J","year":"2018","journal-title":"Acta Derm Venerol"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.09.006"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.0001"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.031"},{"issue":"7","key":"CIT0043","first-page":"800","volume":"17","author":"Cheng MW","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.038"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.4103\/ijt.ijt_21_18"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.03.024"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-017-0069-z"},{"issue":"2","key":"CIT0048","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaad.2017.10.043","volume":"78","author":"Craiglow BG","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.12.041"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.7326\/L16-0125"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1177\/1203475418760512"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13598"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.02.007"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.260"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.12.016"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2017039"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.18295\/squmj.2019.19.01.015"},{"issue":"2","key":"CIT0058","first-page":"47","volume":"26","author":"Erduran F","year":"2017","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1159\/000450848"},{"issue":"8","key":"CIT0060","first-page":"914","volume":"17","author":"Brown L","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14644"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1159\/000445182"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2491"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.07.018"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.04.006"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2016.09.008"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805958"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.05.098"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.0866"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.08.009"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key366"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.03.003"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.12.003"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0140"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13672"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.10.044"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2016.10.009"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12656"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3574-0"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.3772"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.10.003"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.10.047"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz015"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011149"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2018.042"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.04.032"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.05.043"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5778"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.1520"},{"key":"CIT0090","unstructured":"ClinicalTrials.gov. Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare: NCT03910543. Bethesda (MD): National Library of Medicine, 2019."},{"key":"CIT0091","unstructured":"ClinicalTrials.gov. Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata: NCT03800979. Bethesda (MD): National Library of Medicine, 2019."},{"key":"CIT0092","unstructured":"ClinicalTrials.gov. Study of Tofacitinib in Refractory Dermatomyositis (STIR): NCT03002649. Bethesda (MD): National Library of Medicine, 2016."}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09546634.2019.1673877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T18:42:00Z","timestamp":1661193720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09546634.2019.1673877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,3]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5,19]]}},"alternative-id":["10.1080\/09546634.2019.1673877"],"URL":"https:\/\/doi.org\/10.1080\/09546634.2019.1673877","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}